Peptide mediated immunosuppression: new developments.
Magee
C C
CC
Laboratory of Immunogenetics and Transplantation, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Sayegh
M H
MH
D000818:Animals; D015704:CD4 Antigens / Q000737:chemistry / Q000276:immunology; D015195:Drug Design; D000939:Epitopes / Q000737:chemistry / Q000494:pharmacology; D006085:Graft Survival / Q000187:drug effects*; D015235:HLA-B Antigens / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D006683:HLA-DQ Antigens / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents; D007519:Isoantigens / Q000737:chemistry / Q000276:immunology*; D008285:Major Histocompatibility Complex; D018448:Models, Immunological; D010446:Peptide Fragments / Q000737:chemistry / Q000494:pharmacology*; D011110:Polymorphism, Genetic
D015704:CD4 Antigens; D000939:Epitopes; D015235:HLA-B Antigens; D006683:HLA-DQ Antigens; D007166:Immunosuppressive Agents; D007519:Isoantigens; D010446:Peptide Fragments